<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Apaolaza PS</submitter><funding>Leona M. and Harry B. Helmsley Charitable Trust</funding><funding>Horizon 2020 Framework Programme</funding><funding>Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)</funding><funding>JDRF</funding><funding>Breakthrough T1D Canada (formerly JDRF Canada)</funding><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>2771-2785</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11604696</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>67(12)</volume><pubmed_abstract>&lt;h4>Aims/hypothesis&lt;/h4>Islet prohormone-processing enzymes convert peptide hormone precursors to mature hormones. Defective beta cell prohormone processing and the release of incompletely processed peptide hormones are observed prior to the onset of diabetes, yet molecular mechanisms underlying impaired prohormone processing during the development of diabetes remains largely unknown. Previous studies have shown that prohormone convertase 1/3 (PC1/3) protein and mRNA expression levels are reduced in whole islets from donors with type 1 diabetes, although whether PC1/3-mediated prohormone processing in alpha and beta cells is disrupted in type 1 diabetes remained to be explored. Herein, we aimed to analyse the expression of PC1/3 in islets from non-diabetic donors, autoantibody-positive don</pubmed_abstract><journal>Diabetologia</journal><pubmed_title>Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.</pubmed_title><pmcid>PMC11604696</pmcid><funding_grant_id>No 115797</funding_grant_id><funding_grant_id>No 945268</funding_grant_id><funding_grant_id>AWD-019767 JDFC 2021</funding_grant_id><funding_grant_id>3-APF-2022-1141-A-N</funding_grant_id><funding_grant_id>5-CDA-2020-949-A-N</funding_grant_id><funding_grant_id>3-COE-2022-1103-M-B</funding_grant_id><funding_grant_id>CIHR PJT-153156</funding_grant_id><pubmed_authors>Apaolaza PS</pubmed_authors><pubmed_authors>Rodriguez-Calvo T</pubmed_authors><pubmed_authors>Boulassel S</pubmed_authors><pubmed_authors>Chen YC</pubmed_authors><pubmed_authors>Lurz Y</pubmed_authors><pubmed_authors>Grewal K</pubmed_authors><pubmed_authors>Verchere CB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.</name><description>&lt;h4>Aims/hypothesis&lt;/h4>Islet prohormone-processing enzymes convert peptide hormone precursors to mature hormones. Defective beta cell prohormone processing and the release of incompletely processed peptide hormones are observed prior to the onset of diabetes, yet molecular mechanisms underlying impaired prohormone processing during the development of diabetes remains largely unknown. Previous studies have shown that prohormone convertase 1/3 (PC1/3) protein and mRNA expression levels are reduced in whole islets from donors with type 1 diabetes, although whether PC1/3-mediated prohormone processing in alpha and beta cells is disrupted in type 1 diabetes remained to be explored. Herein, we aimed to analyse the expression of PC1/3 in islets from non-diabetic donors, autoantibody-positive don</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-02T10:41:26.911Z</modification><creation>2025-04-04T01:24:12.625Z</creation></dates><accession>S-EPMC11604696</accession><cross_references><pubmed>39404844</pubmed><doi>10.1007/s00125-024-06275-5</doi></cross_references></HashMap>